Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 91: 1836-1844, 2001;
8750-7587/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imai, Y.
Right arrow Articles by Miyasaka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, Y.
Right arrow Articles by Miyasaka, K.
Vol. 91, Issue 4, 1836-1844, October 2001

Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation

Yumiko Imai1,2, Satoshi Nakagawa1, Yushi Ito1, Toshio Kawano1, Arthur S. Slutsky2, and Katsuyuki Miyasaka1

1 Pathophysiology Research Laboratory, National Children's Medical Research Center, Tokyo 154-8509, Japan; and 2 Division of Respiratory and Critical Care, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada M5B 1W8


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study compared pathophysiological and biochemical indexes of acute lung injury in a saline-lavaged rabbit model with different ventilatory strategies: a control group consisting of moderate tidal volume (VT) (10-12 ml/kg) and low positive end-expiratory pressure (PEEP) (4-5 cmH2O); and three protective groups: 1) low VT (5-6 ml/kg) high PEEP, 2-3 cmH2O greater than the lower inflection point; 2) low VT (5-6 ml/kg), high PEEP (8-10 cmH2O); and 3) high-frequency oscillatory ventilation (HFOV). The strategy using PEEP > inflection point resulted in hypotension and barotrauma. HFOV attenuated the decrease in pulmonary compliance, the lung inflammation assessed by polymorphonuclear leukocyte infiltration and tumor necrosis factor-alpha concentration in the alveolar space, and pathological changes of the small airways and alveoli. Conventional mechanical ventilation using lung protection strategies (low VT high PEEP) only attenuated the decrease in oxygenation and pulmonary compliance. Therefore, HFOV may be a preferable option as a lung protection strategy.

ventilator-induced lung injury; volume recruitment; tumor necrosis factor; conventional mechanical ventilation


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

MECHANICAL VENTILATION IS essential for patients with respiratory or ventilatory failure. However, the ventilatory strategies used in many patients with the acute respiratory distress syndrome (ARDS) or acute lung injury may worsen the lung injury. A number of experimental studies have demonstrated that a ventilatory strategy that overdistends alveolar units and/or allows repeated tidal collapse and reopening of damaged lung units may induce lung injury. This indicates that both the magnitude of cyclic fluctuations of alveolar volume [tidal volume (VT)] and the level of end-expiratory alveolar volume may be important in ventilator-induced lung injury (VILI) (11, 31, 40).

Various "lung protection" strategies have been developed to minimize VILI. One strategy uses conventional mechanical ventilation (CMV) with decreased VT and increased positive end-expiratory pressure (PEEP), titrated to the pressure-volume (P-V) curve. Amato and co-workers (2) showed improved survival and decreased incidence of barotrauma in a group treated with an "open lung" approach that employed volume recruitment maneuvers, higher PEEP levels (adjusted on the basis of an initial P-V curve), and a VT of 6 ml/kg. Ranieri and co-workers (34) used a similar strategy and reported a decrease in pulmonary and systemic cytokines in patients with ARDS. More recently, the ARDS Net investigators reported a 22% decrease in mortality of patients with ARDS using a protective conventional strategy aimed at reducing end-inspiratory stretch. This study used a small VT (6 ml/kg predicted body wt) with a PEEP that averaged ~9 cmH2O (1).

These strategies are based on the same concepts underlying the protective advantages of high-frequency oscillatory ventilation (HFOV) (13, 26). HFOV allows the use of extremely small VTs, often less than the anatomical dead space. During HFOV, it is possible to maintain end-expiratory lung volume higher up on the deflation P-V relationship without inducing concurrent overdistention because of the much smaller VTs used (13). There are convincing animal data indicating reduced lung injury with HFOV. Studies in premature primates and saline-lavaged adult rabbits demonstrated that, when compared with conventional ventilation, HFOV improves gas exchange, promotes uniform lung inflation, and reduces lung injury (10, 27, 45). HFOV is also associated with reduced inflammatory mediators and granulocytes in lung lavage samples when compared with conventional ventilation (18, 25, 42, 43).

Thus there are two general ventilatory approaches to lung protection, one based on conventional ventilation and one based on high-frequency ventilation. It is unclear from the literature whether there is an advantage of one approach over the other. The present study set out to examine this issue using a rabbit lung lavage model. We compared different ventilatory strategies: a control group consisting of moderate VT (10-12 ml/kg) and low PEEP (4-5 cmH2O) (MVLP), and three protective groups: 1) low VT (5-6 ml/kg) high PEEP, 2-3 cmH2O greater than the lower inflection point (Pinf); 2) low VT (5-6 ml/kg), high PEEP (8-10 cmH2O) (LVHP); and 3) HFOV. End points were pathophysiological indexes of acute lung injury: gas exchange, lung compliance, the number of polymorphonuclear leukocytes (PMN), levels of tumor necrosis factor-alpha (TNF-alpha ) in lung lavage fluid, and lung pathology.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The study protocol was reviewed and approved by the Institutional Animal Research Committee.

Animal Preparation

Adult male Japanese White rabbits (2.5-3.2 kg) were premedicated with an intramuscular injection of ketamine hydrochloride (10 mg/kg). A venous line was established for fluid maintenance, and the animals were anesthetized and paralyzed by a continuous intravenous infusion of ketamine (8 mg/h) and pancuronium bromide (0.3 mg/h) in 10 ml · kg-1 · h-1 of 5% dextrose in Ringer lactate solution. A tracheostomy was performed, and a 4.0-mm-ID endotracheal tube was inserted and fixed in place while the animal was manually ventilated at an inspired O2 fraction (FIO2) of 1.0 for 3-4 min. Immediately after tracheostomy, ventilation was initiated with a piston pump HFOV ventilator (Humming V; Senko Medical Instrument Manufacturers, Tokyo, Japan). We used HFOV for preparation and stabilization, as described later in detail, because we and others have previously demonstrated that HFOV minimizes lung injury in this saline-lavaged rabbit lung model (16, 18, 25, 42, 43). Sinusoidal volume changes were delivered at an FIO2 of 1.0, an oscillatory frequency of 15 Hz, and a mean airway pressure (MAP) of 7 cmH2O. The stroke volume was adjusted to keep arterial CO2 partial pressure (PaCO2) levels between 30 and 50 Torr. Blood pressure was measured through a fluid-filled catheter in the carotid artery. Arterial blood gases were intermittently measured by a pH/blood-gas analyzer (model 178, Corning, Medfield, MA). Systemic arterial blood pressure was continuously monitored by a pressure transducer (CDX-3, Cobe Laboratories), and body temperature was maintained between 38 and 39°C with a servo-controlled radiant heater and a heating pad.

After stabilization, the rabbits' lungs were lavaged with 30 ml/kg of warmed normal saline to remove lung surfactant. The solution was flushed in and out of the lungs five times, and the saline was gently sucked out at the end of each lavage. This procedure was repeated two times by using the same protocol described by Hamilton et al. (16). The fluid obtained from the lavage procedure was stored and analyzed as the "before ventilation" control. The percentage of lavage fluid recovered was 81 ± 6%.

MAP was raised by 5 cmH2O, and a sustained inflation (SI) to 30 cmH2O for 15 s was performed several times after the lavage for all experiments. After completion of this procedure, MAP was set at 15 cmH2O and stabilized, PaCO2 levels were maintained between 30 and 50 Torr by adjusting stroke volume, and the frequency was fixed at 15 Hz during HFOV. With several SI maneuvers, the arterial O2 partial pressure (PaO2) of the animals soon returned to prelavage levels, i.e., >350 Torr.

Experimental Protocol

Pilot study using a PEEP > lower Pinf strategy. To determine whether HFOV is better or worse than a conventional strategy requires the use of a specific conventional strategy. Because there is no generally agreed on optimal strategy, we chose to study two strategies that have been shown to decrease mortality in two recent randomized controlled trials: 1) a strategy similar to that of Amato et al. (2) with small VT and PEEP > Pinf, and 2) a strategy similar to the National Institutes of Health (NIH) trial (1) using small VT and PEEP ~10 cmH2O. We started with a pilot study to assess the feasibility of using a strategy based on Pinf in this rabbit model. In eight animals, after preparation of the animals and lung lavage as described above, we inflated the lungs twice to an airway opening pressure of 30 cmH2O and then measured a quasi-static P-V curve of the respiratory system. The quasi-static P-V curve was constructed by slowly, manually inflating the lungs using fixed-volume steps up to a pressure of 30 cmH2O. The deflation loop of the static P-V curve was then constructed by withdrawing air in the same manner. The Pinf was determined as described by Matamis et al. (24). After a SI to 30 cmH2O for 15 s was performed several times, the animals were ventilated by using the CMV mode of the Humming V (time-cycled with pressure-limited ventilation mode) with a low VT (5-6 ml/kg) and PEEP 2-3 cmH2O > Pinf (n = 4) for 4 h using an FIO2 of 1.0. VT was maintained at 5-6 ml/kg by adjusting peak inspiratory pressure (PIP). VT, PIP, and MAP were monitored at the proximal end of the endotracheal tube with the airway monitoring mode of a pulmonary function monitor (model GM250 navigator; Newport Medical Instruments, Newport Beach, CA). PEEP was monitored at the same site with a pressure transducer. Arterial blood gases were measured every hour, and systemic arterial blood pressure was continuously monitored. Although we achieved excellent oxygenation, three of four animals developed systemic hypotension and metabolic acidosis and/or pneumothorax. Therefore, in the second set of experiments, we used a value of PEEP = 8-9 cmH2O at the beginning of the first 1 h and 10 cmH2O over the following 3 h in the low VT, high PEEP (LVHP) group. We also used a VT of 5-6 ml/kg in the LVHP group, volumes that are very similar to those used in the recently reported NIH ARDS Net trial (1).

Main experiment. Given the results of the pilot study, the main set of experiments was carried out with the use of a protective ventilatory strategy that is similar to the recently reported NIH trial (1). The rabbits were randomly divided into three groups [MVLP (n = 7), LVHP (n = 6), and HFOV (n = 6)] and were then ventilated for 4 h at an FIO2 of 1.0. In the MVLP group, PEEP was 4-5 cmH2O and VT was maintained at 10-12 ml/kg by adjusting PIP. In the LVHP group, PEEP was set at 8-9 cmH2O for the first hour and then gradually increased to 10 cmH2O over the following 3 h, so as to minimize the systemic hypotension. VT was maintained at 5-6 ml/kg by adjusting PIP. In the HFOV group, MAP was set at 15 cmH2O. Normocapnia was achieved by altering the stroke volume of the piston. Arterial blood gases were measured every hour with a blood-gas analyzer (model 178, Corning). Total respiratory compliance (Crs) was measured before lung lavage and after 4 h of ventilation. The animals were killed by KCl injection at the termination of the experiment, and the lungs were excised via a midline sternotomy. The left lung was then lavaged two times using 15 ml/kg aliquots of normal saline. The drained lavage fluid was collected as in the sample after ventilation. The percentage of lavage fluid recovered was 67 ± 9%. The right lung was fixed with an instillation of 10% buffered formalin at a transpulmonary pressure of 15 cmH2O. We compared pathophysiological indexes as follows: gas exchange, Crs before lung lavage and after 4 h of ventilation, numbers of PMN, the levels of TNF-alpha in the lung lavage fluid, and lung pathological findings at the end of the experiment.

Measurement of Crs

We measured Crs with the static occlusion method by using the passive mechanics (occlusion) mode of a pulmonary function monitor (model GM250 navigator, Newport Medical Instruments). Airway pressures and volumes were measured both at the beginning of inspiration and at the occlusion plateau by using pressure and flow transducers. Crs was then automatically calculated by using linear regression as the chord slope of the P-V line.

Cells, PMN, and Macrophage Counts in Lung Lavage Fluid

The total number of lavaged cells was counted by a standard hemocytometer. Cells were differentiated by use of Wright-Giemsa-stained preparations, and the percent of PMN and macrophages was assessed.

Measurement of TNF-alpha Concentrations in the Lung Lavage Fluid

TNF-alpha concentrations in the lung lavage fluid were assayed using a sandwich ELISA based on the cytokine ELISA protocol of PharMingen (San Diego, CA) as described previously (17). These assays were performed using a purified polyclonal goat anti-rabbit TNF-alpha antibody as a capture antibody and biotinylated polyclonal goat anti-rabbit TNF-alpha antibody for detection. The rabbit TNF-alpha -conditioned medium (PharMingen) was used as a standard, and samples were run in duplicate. The limit of detection in this assay was 50 pg/ml, and linear standard curves were obtained ranging from 75 to 15,000 pg/ml.

Histopathological Examination

After fixation, the right lung was floated in 10% formalin for at least 24 h. The lung was then serially sectioned in a coronal fashion from apex to base, and four random sections from a lung were processed for pathological analysis and embedded in paraffin. Thereafter, each section was sliced to 5 µm and was stained with hematoxylin-eosin and Masson's trichrome. We assessed the lungs (four sections per lung) using a five-point scale according to combined assessments of alveolar congestion, hemorrhage, infiltration or aggregation of neutrophils in the air space or vessel walls, thickness of the alveolar wall, and hyaline membrane formation. The scoring was as follows: 0 = minimal (little) damage, 1+ = mild damage, 2+ = moderate damage, 3+ = severe damage, and 4+ = maximal damage.

Membranous bronchioles are conducting airways without cartilage and include terminal bronchioles, which are the most distal generation of membranous bronchioles and the patent generation to respiratory bronchioles. Four membranous bronchioles per section (16 bronchioles per lung) were processed for pathological scoring. Six pathological abnormalities were evaluated, including degree of inflammatory cell infiltration, fibrosis, smooth muscle hypertrophy, presence of pigment, goblet cell metaplasia, and squamous cell metaplasia. We assigned a score ranging from 0 (normal) to 3 for each of these pathological variables. The airway changes were evaluated by the method of Wright et al. (51), compared with a panel of standard photographs (kindly provided by J. C. Hogg, St. Paul's Hospital, Vancouver, Canada).

Data Analysis

Results are presented as means ± SD. We used a two-way ANOVA to determine the statistical significance of intergroup differences in blood-gas data at different time points, Crs, numbers of PMN in the final lavage fluid, the levels of log TNF-alpha in the lung lavage fluid before and after ventilation, and the scoring of lung pathology. A P value <0.05 was considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Pilot Study

After lung lavage, the lower Pinf was 9.3 ± 1.1 cmH2O. As described above, because we had profound hypotension and gross barotrauma in this group of animals, we did not complete any other analysis on this group.

Main Experiment

Gas exchange. The ventilation protocols resulted in no significant differences in MAP (Fig. 1). PaO2 was highest in the HFOV group and lowest in the MVLP group. PaO2 of the LVHP group was between the values of HFOV and MVLP groups (Fig. 2). PaCO2 was higher in the LVHP group than in the MVLP or HFOV groups, and pH was lower in the LVHP group than in the MVLP or HFOV groups (Fig. 3). The values of Crs after ventilation were lower in the MVLP group than in the HFOV and LVHP groups (P < 0.01) and were also lower in the LVHP group than in the HFOV group (P < 0.05) (Fig. 4).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Left: time course of changes in peak inspiratory pressure in the moderate tidal volume (VT), low positive end-expiratory pressure (PEEP) (MVLP) and low VT, high PEEP (LVHP) groups. Right: mean airway pressure in the MVLP, LVHP, and high-frequency oscillatory ventilation (HFOV) groups. Values are means ± SD. **P < 0.01, compared with LVHP group.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of changes in arterial PO2 (PaO2) in the MVLP, LVHP, and HFOV groups. Values are means ± SD. **P < 0.01 compared with MVLP group. +P < 0.01 compared with HFOV group.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Time course of changes in arterial PCO2 (PaCO2) (left) and pH (right) in the MVLP, LVHP, and HFOV groups. Values are means ± SD. **P < 0.01 compared with LVHP group. *P < 0.05 compared with LVHP group.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Changes of respiratory compliance before lung lavage and after 4 h of ventilation in the MVLP, LVHP, and HFOV groups. Values are means ± SD. *P < 0.05 compared with LVHP group. **P < 0.01 compared with MVLP group.

Cell and PMN count. Following the ventilatory period, the recovered cells from the lung lavage included macrophages and PMN. The number of PMN was lower in the HFOV group than in the LVHP and MVLP groups (P < 0.01). No significant differences were seen between the LVHP and MVLP groups (Fig. 5).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5.   Numbers of polymorphonuclear leukocyte (PMN) cells in the lung lavage fluid at termination of ventilation. Values are means ± SD. Numbers of PMN were significantly higher in the MVLP and LVHP groups than in the HFOV group. **P < 0.01 compared with HFOV group; n.s., not significant.

Levels of TNF-alpha in the lung lavage fluid before and after ventilation. Levels of TNF-alpha in the lung lavage fluid before ventilation were not significantly different among the three groups. Levels of TNF-alpha after ventilation were lower in the HFOV group (436 ± 177 pg/ml) than in the MVLP group (7,366 ± 5,023 pg/ml) (P < 0.01) or in the LVHP group (4,310 ± 1,091 pg/ml) (P < 0.05). No significant differences were seen between the MVLP and LVHP groups, although there was a tendency to lower levels in the LVHP group (Fig. 6).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Levels of tumor necrosis factor-alpha (TNF-alpha ) in the lung lavage fluid before ventilation and at termination of ventilation in the MVLP, LVHP, and HFOV groups. Values are means ± SD. *P < 0.05 compared with HFOV. **P < 0.01 compared with HFOV. Levels of TNF-alpha after ventilation were higher in the MVLP and LVHP groups than in the HFOV group, and no significant differences were seen between MVLP and LVHP groups.

Histopathology. Similar to previous studies (16, 17, 20, 25) the pathological findings from the animals in the MVLP group showed extensive hyaline membrane formation and severe PMN infiltration (Fig. 7A). Expanded lung parenchyma with well-preserved alveoli and less hyaline membranes were seen in the lung samples in the HFOV group (Fig. 7C). In the LVHP group, alveolar injury was severe and similar to the findings in the MVLP group (Fig. 7, A and B). The pathological scores are summarized in Table 1. The quantitative alveolar pathological scores were higher in the MVLP and LVHP groups than in the HFOV group (P < 0.01). No significant differences were seen between the MVLP and LVHP groups (Table 1). Pathological findings of the membranous bronchioles in the MVLP group exhibited a high degree of bronchiolar inflammation, a moderate degree of goblet cell and squamous cell metaplasia, and a low degree of fibrosis and muscular hypertrophy (Fig. 8A). In the HFOV group, the degree of bronchiolar injury was less, especially with regard to inflammation and squamous cell metaplasia (Fig. 8C). In the LVHP group, the degree of injury was between the scores of the MVLP and HFOV groups (Fig. 8B). Results of the individual scores are presented in Table 2. The pathological score with respect to membranous bronchioles was higher in the MVLP group than in the LVHP and HFOV groups (P < 0.01).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 7.   Photomicrographs of alveoli from the animals in the MVLP (A), LVHP (B), and HFOV groups (C) (hematoxylin-eosin stain; original magnification ×400).


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Alveolar pathological score



View larger version (53K):
[in this window]
[in a new window]
 
Fig. 8.   Photomicrographs of membranous bronchioles from the animals in the MVLP (A), LVHP (B), and HFOV groups (C) (Masson's trichrome stain; original magnification ×400).


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Pathological score in membranous bronchioles


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The major findings of this study were 1) ventilation with low VT and high PEEP attenuated the decrease in oxygenation and pulmonary compliance observed with moderate VT and low PEEP but did not attenuate lung inflammation characterized by PMN infiltration and TNF-alpha production, 2) HFOV attenuated the decrease in oxygenation and pulmonary compliance, as well as PMN infiltration and TNF-alpha production, compared with strategies using moderate VT and low PEEP or low VT and high PEEP, and 3) HFOV attenuated the injury to the alveoli and membranous bronchioles.

The major question in interpreting the results of this study is whether the protective ventilatory strategy using CMV was optimal or at least an accepted conventional lung protective strategy. There is no consensus on what constitutes the optimal strategy, and it is not reasonably possible to ascertain whether a given strategy is "optimal" in terms of outcome. It is, however, possible to assess whether the strategy fulfills present concepts of being adequate for lung protection. The key features of a lung protective strategy are recruitment of the lung and minimization of end-inspiratory stretch (11). We initially used a strategy similar to that used by Amato et al. (2) in which the PEEP was 2-3 cmH2O greater than the lower Pinf base on the inflation limb of the P-V curve. Muscedere and colleagues (28) demonstrated that the use of PEEP > Pinf attenuated lung injury in isolated, nonperfused, lavaged rat lungs. The concept is that Pinf represents the point of initiation of recruitment that such a strategy should lead to greater recruitment of lung than lower levels of PEEP. However, there are a number of questions about the validity of this approach including 1) the fact that the lung is often not fully recruited even if PEEP > Pinf, 2) the effect of the chest wall on Pinf, and 3) the spatial heterogeneity of the disease process in ARDS so that a given value of PEEP may be appropriate for one lung region but too large (or too small) for another region. In our rabbit lung lavage model, this strategy led to hypotension and barotrauma, similar to results of Rimensberger et al. (35). This is in contrast to the study by Amato and colleagues (2), which demonstrated a significant difference in their primary end point (28-day mortality) in their lung protective group, which included a strategy that used PEEP > Pinf. Although such a strategy may be advantageous in humans with ARDS (2), our results may indicate greater sensitivity of this anesthetized rabbit model to hemodynamic compromise with changes in airway pressure, perhaps because of the relatively lower chest wall elastance of rabbits vs. human (36) and/or the relatively smaller volume of the thorax, which may impact on the mechanical compression of the heart caused by PEEP (30).

We then used a strategy similar to that used in the ARDS Net trial (1). In that study, VT was 6 ml/kg (predicted body wt) and PEEP averaged 9 cmH2O. Our LVHP strategy thus fulfilled the two criteria mentioned above for an adequate lung protective strategy: PIP was <25 cmH2O, below values thought to be safe (39), and PaO2 was >300 Torr, indicating adequate recruitment. Further evidence for the adequacy of this approach comes from Rimensberger and colleagues (35), who documented that volume recruitment maneuvers allowed expansion of atelectatic lung units during small VT (5 ml/kg) ventilation and that a PEEP above Pinf was not necessary to maintain recruited lung volume in the same model we used, the saline-lavaged rabbit. Thus it is reasonable to treat the LVHP group as a protective conventional strategy (albeit, possibly not optimal).

Compared with the MVLP group, the LVHP group had improved oxygenation and respiratory compliance. This finding has a number of possible explanations. Mechanical ventilation can result in surfactant loss and in the conversion of surfactant from large aggregates to functionally inferior small aggregates, which may occur to a greater extent in injured lungs. A study in a rabbit lung injury model showed that conversion of large to small aggregates was minimized with a low VT (5 ml/kg) strategy (19). Reduced surfactant conversion to small aggregates may have improved compliance and facilitated oxygenation in the LVHP group. Using computed tomography, Gattinoni and colleagues (14) examined the topographic distribution of gas in injured lungs of ARDS patients and documented that a major factor in the apparent decrease in compliance in patients with ARDS is that the inflated portion of the lung represents a small portion of the total lung volume ("baby-lung" concept). To the extent that certain regions of the lung did not maintain recruitment in the MVLP group, this concept could partly explain the decreased compliance observed in the MVLP group compared with the lungs of the LVHP group. More recently, using parenchymal marker technique, Martynowicz and colleagues (23) documented that regional tidal expansion of dependent regions was significantly reduced after oleic acid injury and was restored by application of PEEP, although oleic acid injury did not lead to the collapse of dependent lung units at functional residual capacity, suggesting an alternative mechanism for topographic variability in regional impedance and lung expansion after injury in a model characterized by marked alveolar flooding.

In the LVHP group, there was a tendency to lower TNF-alpha concentrations than the MVLP group, but these values were markedly higher than the HFOV group. These results are similar to those of Tremblay and colleagues (44), who found that their MVHP group (VT = 15 ml/kg, PEEP = 10 cmH2O) was associated with an ~50% decrease in TNF-alpha compared with a group with the same VT but zero PEEP in isolated, ex vivo nonperfused rat lungs. This decrease in TNF-alpha was roughly the same as we observed, but the differences did not reach statistical significance in either study.

HFOV, compared with MVLP and LVHP, resulted in attenuation of the decrease in oxygenation, pulmonary compliance, as well as PMN infiltration and TNF-alpha production in the alveolar space. Our results suggest that the recruitment of lung volume and the limitation of alveolar pressure changes during the respiratory cycle using HFOV may reduce the lung injury caused by mechanical ventilation, compared with CMV with MVLP or even LVHP. Ranieri and colleagues (33) demonstrated that patients with ARDS often have no clear Pinf, suggesting a broad distribution of opening pressures in a nonhomogeneously injured lung. The lung has a spectrum of alveolar volumes and opening and closing pressures that could be affected by gravitational factors and the distribution of the intrinsic lung pathology. HFOV may have a larger margin of safety in keeping the lung open within the desired target range of alveolar reexpansion in nonhomogeneously injured lungs, compared with CMV even with LVHP. Venegas and Fredberg (47) studied the selection of frequency and PEEP values for ventilation of the atelectasis prone lung. They predicted that the range of "safe" frequency-PEEP combinations will be narrow and move to higher frequencies as lung compliance decreases, possibly suggesting the theoretical advantage of HFOV over CMV with MVLP or even with LVHP in noncompliant lungs.

In our previous study using the same model, we confirmed that only 1 h of CMV (MVLP) produced large increases in TNF-alpha mRNA in intra-alveolar cells (43) and also found that the levels of TNF-alpha protein in lung lavage fluid were increased after 4 h of ventilation with CMV (17). Furthermore, polyclonal anti-TNF-alpha antibody attenuated lung injury and the decrease in oxygenation after lung lavage in animals ventilated with CMV (MVLP) (17), suggesting the importance of TNF-alpha in this model. In the present study, we found a significantly lower concentration of TNF-alpha in the lung lavage fluid in the HFOV group, compared with the MVLP or the LVHP group. In other models, injurious ventilatory strategies have been shown to increase TNF-alpha in the circulation draining an ex vivo perfused lung (50) or in the systemic circulation in vivo in an acid aspiration rat model (7). Ranieri et al. (34) demonstrated that a protective ventilatory strategy produced a significant decrease in lavage and serum TNF-alpha in humans. We do not mean to imply that TNF-alpha is the only, or even the key, mediator released during VILI. Indeed, other studies have suggested that TNF-alpha may not play a key role in VILI (32, 48, 49). Pugin et al. (32) and Vlahakis et al. (49) found no increase in TNF-alpha in stretched cell culture systems. Verbrugge and colleagues (48) used an in vivo rat lung lavage model and found that there were no statistically significant increases in bronchoalveolar lavage TNF-alpha concentrations among animals treated with different ventilatory strategies. Other chemokines or proinflammatory mediators such as interleukin (IL)-8 or IL-1beta and anti-inflammatory mediators such as IL-10 have been measured in other studies, but these cytokines were not measured in the present study. The balance of these pro- and anti-inflammatory mediators is known to be important in the cytokine network in the lung.

No significant differences in pathological changes in the alveoli were seen between the MVLP and LVHP groups. Our results are different from those of some other investigators (3, 9, 37). Corbridge and colleagues (9) studied different ventilatory strategies in a canine acid-aspiration model and concluded that ventilation with high VT and low PEEP augments lung edema and that PEEP protects against surfactant depletion. They used a VT of 30 ml/kg in the high-VT and low-PEEP group, which was markedly larger than our moderate VT (10-12 ml/kg). In contrast, membranous bronchiole pathological changes were greater in the MVLP group than in the LVHP group, consistent with the results of Muscedere and colleagues (28). During ventilation, a pressure wave is generated and travels down the airway, and at each point of the open airway the pressure is transmitted to the airway wall tangentially, producing large shear stresses, especially in regions where airways are collapsed; this may be responsible for the observed changes in the membranous bronchioles in the MVLP group. In the LVHP group, the degree of PEEP used may have been sufficient to keep the membranous bronchioles open at end-expiration. This could have protected these regions from repeated opening and closing, thus attenuating the trauma observed in the MVLP group. It is possible that membranous bronchioles were also held open during HFOV with a mean airway pressure of 15 cmH2O with only a small pressure oscillation around this and were not subjected to further trauma.

The increased injury in the MVLP group is unlikely to be due to the lower PaCO2 in this group because hypercapnic acidosis has been shown to attenuate lung injury in an isolated perfused rabbit model, possibly related to inhibition of endogenous xanthine oxidase (21, 22, 38). HFOV is thought to be an option of lung protection strategy without hypercapnia. In some clinical settings such as elevated intracranial pressure or inability to buffer CO2 adequately in the context of renal failure, these adverse effects of hypercapnia limit the use of "permissive hypercapnia."

It has been suggested that mechanical ventilation used in patients with ARDS may serve to initiate and/or potentiate an inflammatory response in the lung that in turn propagates a vicious cycle of inflammation leading to tissue injury locally and possibly systemically (41, 46, 50). Results from our study suggest that the lower levels of lung inflammation and TNF-alpha in the HFOV group compared with CMV may be associated with a lower likelihood of propagation of this vicious cycle of inflammation.

Early prospective, controlled clinical trials were unable to demonstrate the superiority of HFOV over CMV (16a). No benefit of HFOV accrued in the high-frequency intervention trial, and HFOV was associated with an increased incidence of air leak, intracranial hemorrhage, and periventricular leukomalacia. It has been suggested that this lack of benefit in the HIFI study was related to the lack of an adequate volume recruitment strategy (5). Recent studies using a volume recruitment strategy demonstrated improved gas exchange, reductions in barotrauma, and overall improved outcome in neonatal patients receiving HFOV (8, 15, 29). More recently, a pilot study demonstrated that HFOV using a protocol designed to obtain recruitment and maintain optimal lung volume was both safe and effective in pediatric and adult patients with ARDS (4, 12). The present study suggests that HFOV may be the preferable option as a lung protection strategy. Further prospective, controlled, clinical trials are needed to compare these two different means of pursuing the same physiological treatment goal, namely, that of recruiting and maintaining lung volume. Furthermore, a strategy with PEEP above Pinf may not be always possible during CMV because of hemodynamic compromise, despite VT reduction, and HFOV, by allowing such recruitment, may be a better lung protective strategy.

In summary, in this lung lavage model HFOV attenuated pulmonary compliance, lung inflammation assessed by PMN infiltration, and TNF-alpha concentration in the alveolar space and pathological changes of the small airways and alveoli. CMV using a protection ventilatory strategy only attenuated the decrease in oxygenation and pulmonary compliance. HFOV may therefore be a preferable option as a lung protection strategy.


    ACKNOWLEDGEMENTS

We are grateful to Dr. A. Charles Bryan for useful comments in preparing this manuscript. We thank Drs. Marc de Perrot and George Volgyesi for kind assistance.


    FOOTNOTES

This research was supported in part by The Ministry of Health and Welfare, Japan (H3-P-K-5), and the Canadian Institutes of Health Research.

Address for reprint requests and other correspondence: K. Miyasaka, National Children's Medical Research Center 3-35-31 Taishido, Setagaya-ku, Tokyo 154-8509, Japan (E-mail: kmiyasaka{at}nch.go.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 18 January 2000; accepted in final form 15 June 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury, and the acute respiratory distress syndrome. N Engl J Med 342: 1301-1308, 2000[Abstract/Free Full Text].

2.   Amato, MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, and Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338: 347-354, 1998[Abstract/Free Full Text].

3.   Argiras, EP, Blakeley CR, Dunnill MS, Otremski S, and Sykes MK. High PEEP decreases hyaline membrane formation in surfactant deficient lungs. Br J Anaesth 59: 1278-1285, 1987[Abstract/Free Full Text].

4.   Arnold, JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, and Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 22: 1530-1539, 1994[ISI][Medline].

5.   Bryan, AC, and Froese AB. Reflections on the HIFI trial. Pediatrics 87: 565-567, 1991[Abstract/Free Full Text].

7.   Chiumello, D, Pristine G, and Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 160: 109-116, 1999[Abstract/Free Full Text].

8.   Clark, RH, Yoder BA, and Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 124: 447-454, 1994[ISI][Medline].

9.   Corbridge, TC, Wood LD, Crawford GP, Chudoba MJ, Yanos J, and Sznajder JI. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 142: 311-315, 1990[ISI][Medline].

10.   DeLemos, RA, Coalson JJ, Gerstmann DR, Null DM, Jr, Ackerman NB, Escobedo MB, Robotham JL, and Kuehl TJ. Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr Res 21: 594-602, 1987[ISI][Medline].

11.   Dreyfuss, D, and Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 157: 294-323, 1998[Free Full Text].

12.   Fort, P, Farmer C, Westerman J, Johannigman J, Beninati W, Dolan S, and Derdak S. High-frequency oscillatory ventilation for adult respiratory distress syndrome---a pilot study. Crit Care Med 25: 937-947, 1997[ISI][Medline].

13.   Froese, AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, and Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 148: 569-577, 1993[ISI][Medline].

14.   Gattinoni, L, Pesenti A, Avalli L, Rossi F, and Bombino M. Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136: 730-736, 1987[ISI][Medline].

15.   Gerstmann, DR, Minton SD, Stoddard RA, Meredith KS, Monaco F, Bertrand JM, Battisti O, Langhendries JP, Francois A, and Clark RH. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 98: 1044-1057, 1996[Abstract/Free Full Text].

16.   Hamilton, PP, Onayemi A, Smyth JA, Gillan JE, Cutz E, Froese AB, and Bryan AC. Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol 55: 131-138, 1983[Free Full Text].

16a.   The HIFI Study Group. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 320: 88-93, 1989[Abstract].

17.   Imai, Y, Kawano T, Iwamoto S, Nakagawa S, Takata M, and Miyasaka K. Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits. J Appl Physiol 87: 510-515, 1999[Abstract/Free Full Text].

18.   Imai, Y, Kawano T, Miyasaka K, Takata M, Imai T, and Okuyama K. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 150: 1550-1554, 1994[Abstract].

19.   Ito, Y, Veldhuizen RA, Yao LJ, McCaig LA, Bartlett AJ, and Lewis JF. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am J Respir Crit Care Med 155: 493-499, 1997[Abstract].

20.   Kawano, T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, and Bryan AC. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 62: 27-33, 1987[Abstract/Free Full Text].

21.   Laffey, JG, Engelberts D, and Kavanagh BP. Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit Care Med 161: 141-146, 2000[Abstract/Free Full Text].

22.   Laffey, JG, and Kavanagh BP. Carbon dioxide and the critically ill---too little of a good thing? Lancet 354: 1283-1286, 1999[ISI][Medline].

23.   Martynowicz, MA, Minor TA, Wilson TA, Walters BJ, and Hubmayr RD. Effect of positive end-expiratory pressure on regional lung expansion of oleic acid-injured dogs. Chest 116: 28S-29S, 1999[Free Full Text].

24.   Matamis, D, Lemaire F, Harf A, Brun-Buisson C, Ansquer JC, and Atlan G. Total respiratory pressure-volume curves in the adult respiratory distress syndrome. Chest 86: 58-66, 1984[Abstract/Free Full Text].

25.   Matsuoka, T, Kawano T, and Miyasaka K. Role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes. J Appl Physiol 76: 539-544, 1994[Abstract/Free Full Text].

26.   McCulloch, PR, Forkert PG, and Froese AB. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis 137: 1185-1192, 1988[ISI][Medline].

27.   Meredith, KS, deLemos RA, Coalson JJ, King RJ, Gerstmann DR, Kumar R, Kuehl TJ, Winter DC, Taylor A, and Clark RH. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 66: 2150-2158, 1989[Abstract/Free Full Text].

28.   Muscedere, JG, Mullen JB, Gan K, and Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149: 1327-1334, 1994[Abstract].

29.   Ogawa, Y, Miyasaka K, Kawano T, Imura S, Inukai K, Okuyama K, Oguchi K, Togari H, Nishida H, and Mishina J. A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure. Early Hum Dev 32: 1-10, 1993[ISI][Medline].

30.   Olson, LE, and Hoffman EA. Heart-lung interactions determined by electron beam X-ray CT in laterally recumbent rabbits. J Appl Physiol 78: 417-427, 1995[Abstract/Free Full Text].

31.   Parker, JC, Hernandez LA, and Peevy KJ. Mechanisms of ventilator-induced lung injury. Crit Care Med 21: 131-143, 1993[ISI][Medline].

32.   Pugin, J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, and Chevrolet JC. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol Lung Cell Mol Physiol 275: L1040-L1050, 1998[Abstract/Free Full Text].

33.   Ranieri, VM, Eissa NT, Corbeil C, Chasse M, Braidy J, Matar N, and Milic-Emili J. Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144: 544-551, 1991[ISI][Medline].

34.   Ranieri, VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, and Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 282: 54-61, 1999[Abstract/Free Full Text].

35.   Rimensberger, PC, Cox PN, Frndova H, and Bryan AC. The open lung during small tidal volume ventilation: concepts of recruitment and "optimal" positive end-expiratory pressure. Crit Care Med 27: 1946-1952, 1999[ISI][Medline].

36.   Ruckebusch, Y, Phaneuf L, and Dunlop R. Physiology of Small and Large Animals. Philadelphia, PA: B. C. Decker, 1991, p. 43-97.

37.   Sandhar, BK, Niblett DJ, Argiras EP, Dunnill MS, and Sykes MK. Effects of positive end-expiratory pressure on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome. Intensive Care Med 14: 538-546, 1988[ISI][Medline].

38.   Shibata, K, Cregg N, Engelberts D, Takeuchi A, Fedorko L, and Kavanagh BP. Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 158: 1578-1584, 1998[Abstract/Free Full Text].

39.   Slutsky, AS. Consensus conference on mechanical ventilation---January 28-30, 1993 at Northbrook, Illinois, USA. Part 2. Intensive Care Med 20: 150-162, 1994[ISI][Medline].

40.   Slutsky, AS. Lung injury caused by mechanical ventilation. Chest 116: 9S-15S, 1999[Free Full Text].

41.   Slutsky, AS, and Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157: 1721-1725, 1998[Free Full Text].

42.   Sugiura, M, McCulloch PR, Wren S, Dawson RH, and Froese AB. Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol 77: 1355-1365, 1994[Abstract/Free Full Text].

43.   Takata, M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, and Miyasaka K. Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med 156: 272-279, 1997[Abstract/Free Full Text].

44.   Tremblay, L, Valenza F, Ribeiro SP, Li J, and Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944-952, 1997[ISI][Medline].

45.   Truog, WE, and Standaert TA. Effect of high-frequency ventilation on gas exchange and pulmonary vascular resistance in lambs. J Appl Physiol 59: 1104-1109, 1985[Abstract/Free Full Text].

46.   Tutor, JD, Mason CM, Dobard E, Beckerman RC, Summer WR, and Nelson S. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 149: 1107-1111, 1994[Abstract].

47.   Venegas, JG, and Fredberg JJ. Understanding the pressure cost of ventilation: why does high-frequency ventilation work? Crit Care Med 22: S49-S57, 1994[ISI][Medline].

48.   Verbrugge, SJ, Uhlig S, Neggers SJ, Martin C, Held HD, Haitsma JJ, and Lachmann B. Different ventilation strategies affect lung function but do not increase tumor necrosis factor-alpha and prostacyclin production in lavaged rat lungs in vivo. Anesthesiology 91: 1834-1843, 1999[ISI][Medline].

49.   Vlahakis, NE, Schroeder MA, Limper AH, and Hubmayr RD. Stretch induces cytokine release by alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 277: L167-L173, 1999[Abstract/Free Full Text].

50.   Von Bethmann, AN, Brasch F, Nusing R, Vogt K, Volk HD, Muller KM, Wendel A, and Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 157: 263-272, 1998[Abstract/Free Full Text].

51.   Wright, JL, Cosio M, Wiggs B, and Hogg JC. A morphologic grading scheme for membranous and respiratory bronchioles. Arch Pathol Lab Med 109: 163-165, 1985[ISI][Medline].


J APPL PHYSIOL 91(4):1836-1844
8750-7587/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
Rebuttal from Drs. Ferguson and Slutsky
J Appl Physiol, April 1, 2008; 104(4): 1233 - 1234.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. D. Ferguson and A. S. Slutsky
Point:Counterpoint: High-frequency ventilation is/is not the optimal physiological approach to ventilate ARDS patients
J Appl Physiol, April 1, 2008; 104(4): 1230 - 1231.
[Full Text] [PDF]


Home page
ChestHome page
K. P. W. Chan, T. E. Stewart, and S. Mehta
High-Frequency Oscillatory Ventilation for Adult Patients With ARDS
Chest, June 1, 2007; 131(6): 1907 - 1916.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. A. Frank, P. E. Parsons, and M. A. Matthay
Pathogenetic Significance of Biological Markers of Ventilator-Associated Lung Injury in Experimental and Clinical Studies
Chest, December 1, 2006; 130(6): 1906 - 1914.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Mehta, J. Granton, R. J. MacDonald, D. Bowman, A. Matte-Martyn, T. Bachman, T. Smith, and T. E. Stewart
High-Frequency Oscillatory Ventilation in Adults: The Toronto Experience
Chest, August 1, 2004; 126(2): 518 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. R. Wilson, S. Choudhury, M. E. Goddard, K. P. O'Dea, A. G. Nicholson, and M. Takata
High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury
J Appl Physiol, October 1, 2003; 95(4): 1385 - 1393.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Y. Imai, J. Parodo, O. Kajikawa, M. de Perrot, S. Fischer, V. Edwards, E. Cutz, M. Liu, S. Keshavjee, T. R. Martin, et al.
Injurious Mechanical Ventilation and End-Organ Epithelial Cell Apoptosis and Organ Dysfunction in an Experimental Model of Acute Respiratory Distress Syndrome
JAMA, April 23, 2003; 289(16): 2104 - 2112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Derdak, S. Mehta, T. E. Stewart, T. Smith, M. Rogers, T. G. Buchman, B. Carlin, S. Lowson, J. Granton, and the Multicenter Oscillatory Ventilation
High-Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome in Adults: A Randomized, Controlled Trial
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 801 - 808.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow